ASTERA LABS INC COMMON STOCK (Ticker: 1ALAB) (ALAB)
NASDAQ (NGS) NASDAQ (NGS) Primary 
Astera Labs: The Market's Overreaction Hands Long-Term Buyers A Gift
Astera Labs: The Market's Overreaction Hands Long-Term Buyers A Gift
The Great Astera Labs Reset
Astera Labs, Inc.'s revenue more than doubled year-over-year, while sequential growth slowed to mid-single digits, triggering valuation compression. ALAB's GAAP operating margin declined from mid-20% levels to below 20% as R&D rose to $93.8M, nearly 35% of revenue. Free cash flow margins remained strong above 30%, with $1.19B cash and zero debt reinforcing ALAB's financial flexibility.
ALAB Rides on Strong Connectivity Demand: What's Ahead for the Stock?
Astera Labs bets on surging AI connectivity demand, expanding NVLink and Scorpio lines as its market opportunity eyes a 10x jump to $25B in five years.
Astera Labs (ALAB) Now 58% Below Wall Street Price Targets Following Earnings Plunge
Astera Labs (Nasdaq: ALAB) closed at $129.32 on February 13, 2026, down 23.86% over the past week.
Astera Labs: Why I Am Still Buying
Astera Labs is central to the AI infrastructure shift, enabling critical rack-level connectivity as hyperscaler capex accelerates. ALAB's multi-product ramp, including Scorpio and optical solutions, positions it as a strategic control point for rack-scale AI systems. Despite trading at a significant valuation premium, I reiterate a strong buy rating due to ALAB's expanding addressable market and unique platform role.
ALAB Stock Dips 31% Post Q4 Earnings: Should You Buy, Hold, or Sell?
Astera Labs tumbles 31% after margin pressure hits Q4, despite AI demand, portfolio expansion, and strong Q1 guidance fueling growth hopes.
Astera Labs: Investors Are Booking Profits After Q4 Earnings
Astera Labs is rated 'hold' due to a rich valuation despite stellar Q4 results and a robust growth outlook. ALAB's diversified AI connectivity portfolio and software ecosystem drive 100%+ YoY revenue growth and expanding margins. Management guides for Q1 2026 revenue of $286-$297 million, citing strong hyperscaler demand and a $25B addressable market.
Astera's Pause Before The Second Surge
Revenue reached $270.6 million, up 17% sequentially and 92% year over year, with 75.7% gross margins and strong cash generation. First-quarter guidance implies 6%–10% sequential growth with gross margin stepping down to ~74% amid rising operating expenses. Scorpio X contributions are modest in early 2026, with meaningful volume ramps weighted toward the second half and into 2027.
Astera Labs Q4 Earnings Beat Estimates, Revenues Rise Y/Y, Shares Fall
ALAB tops Q4 earnings and revenue estimates on AI-driven growth, but shares tumble nearly 12% despite strong year-over-year gains.
Why Amazon's $6.5 billion chip deal with Astera Labs is a ‘double-edged sword'
Shares of Astera Labs tumbled on Wednesday despite a fourth-quarter earnings beat, as investors questioned the merits of the large deal with Amazon.
Astera Labs, Inc. (ALAB) Q4 2025 Earnings Call Transcript
Astera Labs, Inc. (ALAB) Q4 2025 Earnings Call Transcript
Astera Labs shares sink 10% as revenue comes up short of some expectations
Astera Labs reported results for the fiscal fourth quarter on Tuesday that exceeded analyst expectations for both earnings per share and revenue. CEO Jitendra Mohan told CNBC that "AI is still in its early innings," issuing strong guidance for the first-quarter of 2026.
